LONNEL COATS
CIK 1612528 · Chief Executive Officer · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.23M
Companies
4
Total Filings
52
Lifetime Open-Market Net
-$1.59M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RLAY | Director | — | $14.81 | — | $0 | 2 | 2026-06-10 |
| Verve Therapeutics, Inc. (VERV) Delisted | Director | — | $11.13 | — | $0 | 5 | 2025-07-28 |
| Blueprint Medicines Corp (BPMC) Delisted | Director | 0 | $129.46 | $0 | -$2.69M | 15 | 2025-07-21 |
| LXRX | Chief Executive Officer | 1,159,439 | $1.92 | $2.23M | $1.11M | 30 | 2024-02-29 |
Recent Filings · Page 3 of 6
52 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-08-09 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-30 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +2,600 | $0 | EDGAR |
| 2022-02-28 | LXRX | Mixed | +149,290 | -$137.0K | EDGAR |
| 2022-02-14 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2021-06-04 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +2,250 | $0 | EDGAR |
| 2021-03-02 | LXRX | Mixed | +137,847 | -$395.7K | EDGAR |
| 2021-02-16 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2020-06-26 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +2,250 | $0 | EDGAR |
| 2020-06-23 | Blueprint Medicines Corp (BPMC) Delisted | Exer (M) | +1,312 | $0 | EDGAR |
| 2020-03-03 | LXRX | Mixed | +71,327 | -$125.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.